Shenzhen Hepalink Pharmaceutical Group

Resverlogix Corp. operates as a late-stage clinical biotechnology company. The company is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trials for patients with cardiovascular, chronic kidney, end-stage renal, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. Resverlogix Corp. is headquartered in Calgary, Canada.

OncoQuest Inc., founded in 2015 and based in Edmonton, Canada, specializes in developing immunotherapeutic products aimed at treating cancer. As a subsidiary of Quest PharmaTech, Inc., the company has assembled a range of bioactive technologies, including human and xenotypic monoclonal antibodies of the IgG and IgE classes. These antibodies are designed to induce tumor-specific immunity and improve clinical outcomes. Several of OncoQuest's lead components have established clinical track records and comprehensive development dossiers, positioning them as key elements in combinatorial immuno-oncology treatment strategies.

Kymab Limited is a biotechnology company based in Cambridge, United Kingdom, that specializes in the discovery, development, and commercialization of human monoclonal antibody therapeutics. Utilizing its proprietary Kymouse platform, Kymab captures the diversity of the human immune system's B lymphocyte component to generate biopharmaceuticals targeting both established and novel drug targets. The company's therapeutic focus spans immuno-oncology, immunology, and other opportunistic areas. Kymab has established strategic collaborations with Heptares Therapeutics and LifeArc to enhance its research and development efforts. Founded in 2009, Kymab continues to advance its pipeline of monoclonal antibody candidates aimed at addressing significant medical needs.

Shanghai Labway Clinical Laboratory Co., Ltd. offers sales services for in vitro diagnostic products; and medical laboratory services. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is based in Shanghai, China.

OncoQuest Inc., founded in 2015 and based in Edmonton, Canada, specializes in developing immunotherapeutic products aimed at treating cancer. As a subsidiary of Quest PharmaTech, Inc., the company has assembled a range of bioactive technologies, including human and xenotypic monoclonal antibodies of the IgG and IgE classes. These antibodies are designed to induce tumor-specific immunity and improve clinical outcomes. Several of OncoQuest's lead components have established clinical track records and comprehensive development dossiers, positioning them as key elements in combinatorial immuno-oncology treatment strategies.

Cytovance Biologics is a full service CDMO specializing in cGMP production of therapeutic proteins & antibodies from mammalian cell culture (CHO), microbial fermentation (Ecoli), and transgenic processes. We offer cell line development, process development services, purification development, stability testing, and more from our FDA inspected, Oklahoma City state-of-the-art facilities.

Rapid Micro Biosystems provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biotechnology, and personal care products. It offers the Growth Direct System, a non-destructive method for microbial enumeration. The company was formerly known as Genomic Profiling Systems and changed its name to Rapid Micro Biosystems in 2007. Rapid Micro Biosystems was founded in 2006 and is based in Bedford, Massachusetts.

Scientific Protein Laboratories is a biopharmaceutical company based in Waunakee, Wisconsin, that specializes in the development and manufacturing of active pharmaceutical ingredients (APIs) for the pharmaceutical, veterinary, and food industries. Founded in 1976, the company produces a range of products, including heparin and pancreatic enzyme products, along with derivatives and custom formulations. Scientific Protein Laboratories offers comprehensive contract services, encompassing natural product extraction, fermentation, purification, and analytical support, aiding clients throughout various stages of clinical development to commercial launch. The company also assists clients with regulatory compliance, providing critical documentation for regulatory filings and offering process validation and equipment qualification services.